Tilray Brands Stock Falls Thursday Despite Market Performance

🌥️Trending News

Thursday was a tough day for Tilray ($NASDAQ:TLRY) Brands Inc. stock, despite the overall market’s performance. Tilray is an American cannabis company that cultivates, processes and distributes cannabis products in the United States and Canada. This decline came despite the company’s recent announcement of their collaboration with large scale beverage producer, Diageo, to develop cannabis-infused drinks. Tilray Brands Inc. stock has been volatile since its initial public offering but appears to be on an upward trend in the long term.

Price History

The stock opened at $1.7 and closed at $1.7, resulting in only a 0.6% increase from the previous closing price. Tilray_Brands_Stock_Falls_Thursday_Despite_Market_Performance”>Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Tilray. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Tilray. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Tilray. More…

Key Ratios Snapshot

Some of the financial key ratios for Tilray are shown below. More…

Analysis

At GoodWhale, we have been analyzing the fundamentals of TILRAY and have come to some interesting conclusions. According to our Star Chart, TILRAY is strong in growth, medium in asset and weak in dividend, profitability. We have classified them as a ‘rhino’, a type of company that has achieved moderate revenue or earnings growth. As such, this company might be attractive to investors looking for a moderate level of returns, with the understanding that there is a lower level of risk associated with such investments. Unfortunately, TILRAY has a low health score of 2/10 with regard to its cashflows and debt, which makes it less likely to sustain future operations in times of crisis. Investors should therefore consider their risk appetite before investing in this stock. The company should also focus on strengthening its financial health in order to ensure its long-term success. More…

Peers

Its competitors are IM Cannabis Corp, Cansortium Inc, and Aurora Cannabis Inc.

– IM Cannabis Corp ($NASDAQ:IMCC)

Organigram Holdings Inc. is a Canada-based company, which offers various cannabis products. The company’s portfolio of brands include ANKR Organics, Edison Cannabis Co., Trailer Park Buds, and The Edison Cannabis Company. It operates through its subsidiary, Organigram Inc. The company offers dried cannabis, cannabis oils, capsules, and pre-rolls. It also provides adult-use recreational cannabis in Canada.

– Cansortium Inc ($OTCPK:CNTMF)

Consortium Inc is a publicly traded company with a market capitalization of $41.63 million as of 2022. The company has a return on equity of 25.1%, meaning that it has generated a profit for shareholders of $25.1 million over the past year. Consortium Inc is a leading provider of engineering and construction services, with a focus on the energy, industrial, and infrastructure markets. The company has a strong track record of delivering quality projects on time and on budget, and has a reputation for being a dependable partner for its clients.

– Aurora Cannabis Inc ($TSX:ACB)

Aurora Cannabis Inc is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and the New York Stock Exchange under the ticker ACB. The company produces and sells medical cannabis products in Canada, the European Union, the United Kingdom, and Australia. Aurora also has operations in Brazil.

Summary

TILRAY is a marijuana and hemp-based products manufacturer, and investors remain divided on its future prospects. Analysts are expecting revenue growth in the next quarter, driven primarily by increasing demand, but caution that this will be partially offset by rising costs and increased competition in the industry. Additionally, there is uncertainty surrounding the regulatory environment in the US, which could limit the availability of Tilray’s products. Despite potential short-term challenges, long-term investors may find value in Tilray due to its innovative products and potential to capitalize on the growing legal cannabis market as more states move to legalize recreational marijuana.